Viruses are obligate intracellular pathogens consisting of genetic material (DNA or RNA) enclosed in a protein coat (capsid) that hijack host cellular machinery to replicate. They trigger innate immunity through pattern recognition receptors (TLR3/7/8/9) detecting viral nucleic acids and activate adaptive immunity with Th1 cellular responses that mobilize cytotoxic T cells to eliminate infected cells. Unlike bacteria, viruses cannot be targeted by antibodies alone once inside cells—they require cell-mediated immunity.
Think of viruses as burglars who don't just steal from your house—they break in, take over your workshop, force your tools to build copies of themselves, then blow up the workshop on their way out, releasing hundreds of new burglars into the neighborhood. Your immune system's response is like a three-phase security operation: First, the alarm system (TLRs) detects the break-in by recognizing viral "fingerprints" (nucleic acids that shouldn't be there). This triggers the neighborhood watch (interferon) to warn all nearby houses: "Lock your doors, don't let anyone in, destroy your workshop if you're already infected." Meanwhile, special inspection teams (NK cells) patrol for houses showing signs of forced entry—they don't wait for confirmation, they just demolish suspicious buildings. Finally, highly-trained detectives (cytotoxic T cells) arrive with wanted posters showing exact photos of the burglars (viral peptides displayed on MHC Class I). These detectives kill every house displaying those photos, ensuring no burglar factories remain operational. This entire operation is enormously expensive—it requires shutting down normal business (fever, inflammation), diverting all energy to security (energy metabolism), and accepting collateral damage. Some burglars (EBV, CMV, HSV) hide in your basement for years, forcing you to keep detectives on permanent patrol, draining your resources indefinitely.
Viral Entry and Replication:
- Attachment and entry: Viruses bind specific cell-surface receptors (e.g., SARS-CoV-2 uses ACE2) → receptor-mediated endocytosis or direct membrane fusion → release of viral genetic material into cytoplasm
- Hijacking machinery: Viral nucleic acids commandeer host ribosomes → translation of viral proteins → viral genome replication using host polymerases → assembly of new virions
- Cell destruction: Infected cells display viral peptides on MHC Class I molecules → cytopathic effect triggers cell death or lysis releases progeny virions
Innate Immune Recognition:
- TLR3: recognizes double-stranded RNA (dsRNA) in endosomes → activates TRIF pathway → IRF3/IRF7 translocation → Type I interferon (IFN-α/β) production
- TLR7/TLR8: detect single-stranded RNA (ssRNA) → MyD88 signaling → NF-κB and IRF7 activation → Type I interferon
- TLR9: recognizes unmethylated CpG DNA motifs → MyD88 pathway → IFN-α production (particularly in plasmacytoid dendritic cells)
- Cytoplasmic sensors: RIG-I and MDA5 detect viral RNA → MAVS signaling → Type I interferon
Type I Interferon Cascade:
graph TD
A[Viral Nucleic Acids] -->|TLR3/7/8/9| B[IRF3/IRF7 activation]
A -->|RIG-I/MDA5| B
B --> C["Type I Interferon IFN-α/β secretion"]
C --> D[Autocrine/Paracrine IFNAR signaling]
D --> E[JAK-STAT pathway]
E --> F[ISG15, OAS, PKR expression]
F --> G["Antiviral state: protein synthesis blocked"]
F --> H[Viral genome degradation]
C --> I[NK cell activation]
C --> J[Dendritic cell maturation]
J --> K[Th1 differentiation]
K --> L["IFN-γ production"]
L --> M[Macrophage activation]
L --> N["CD8+ T cell priming"]
N --> O[Cytotoxic killing of infected cells]
Adaptive Immune Response:
- Dendritic cells present viral antigens on MHC Class I and MHC Class II
- CD8+ T cells recognize MHC I-peptide complexes → clonal expansion → perforin/granzyme-mediated killing of infected cells
- CD4+ Th1 cells produce IFN-γ → enhances macrophage antiviral activity, sustains CD8+ responses
- NK cells provide early defense by killing cells with downregulated MHC I (viral escape mechanism)
- B cells produce neutralizing antibodies → block viral entry (extracellular phase only)
Viral Latency Mechanisms:
- EBV: infects B cells → circular episomal DNA in nucleus → latent membrane proteins (LMP1/2) drive B cell survival without lytic replication
- CMV: persists in myeloid progenitors → reactivates during immunosuppression
- HSV: establishes latency in dorsal root ganglia neurons → LAT (latency-associated transcript) prevents lytic gene expression
Mitochondrial Damage:
Why This Matters in cPNI:
Viral infections represent a fundamental evolutionary challenge requiring massive energy reallocation from growth, reproduction, and repair to immune defense. This aligns with the selfish immune system principle—during acute viral infection, the immune system commandeers up to 30% of ATP production, manifesting as fever, sickness behaviour, muscle wasting, and metabolic shutdown. Chronic or latent viral infections (EBV, CMV, HSV) force the immune system into permanent surveillance mode, depleting metabolic flexibility and predisposing to immune exhaustion.
Relevant Patient Populations:
Clinical Thresholds:
- EBV serology: VCA IgG >750 U/mL suggests chronic high viral load; EBNA IgG absence with VCA IgM indicates acute infection
- CMV IgG >250 AU/mL: indicates past infection; rising titers suggest reactivation
- Interferon-gamma release assays: <0.35 IU/mL indicates poor Th1 function
Intervention Implications:
-
Th1 Support:
- Vitamin D (maintain 25(OH)D >75 nmol/L): enhances cathelicidin (LL-37) and beta-defensin production
- Zinc (15-30 mg/day): required for thymulin secretion and IFN-γ signaling
- Selenium (200 mcg/day): selenoproteins essential for glutathione peroxidase → protects against oxidative burst
-
Interferon Optimization:
- Cold exposure: mild cold stress upregulates Type I interferon genes
- Sleep: deep sleep enhances interferon production (nadir at 02:00-04:00, peaks after 6+ hours sleep)
-
Mitochondrial Protection:
-
Distinguish Viral from Bacterial:
- Viral: gradual onset, systemic symptoms, lymphocytosis, requires Th1 support
- Bacterial: rapid onset, localized symptoms, neutrophilia, may require Th17 activation (e.g., vitamin A)
Evolutionary Mismatch:
Modern hygiene reduces early-life viral exposures, impairing trained immunity. Conversely, chronic psychological stress elevates cortisol, suppressing Th1 and reactivating latent viruses—creating a vicious cycle of inflammation, HPA axis dysregulation, and metabolic exhaustion.
- Obligate intracellular pathogens requiring host ribosomes, polymerases, and ATP for replication
- Detected by TLR3 (dsRNA in endosomes), TLR7/8 (ssRNA), TLR9 (unmethylated CpG DNA motifs)
- Type I interferon (IFN-α/β) is the primary antiviral cytokine, inducing antiviral genes (ISG15, OAS, PKR) in surrounding cells
- Viral infections require Th1 cellular immunity (IFN-γ, CD8+ cytotoxic T cells)—antibodies alone cannot clear intracellular pathogens
- EBV infects >90% of adults by age 40; persists latently in B cells; reactivates during stress or immunosuppression
- CMV seropositivity increases with age (50% by age 40, 90% by age 80 in some populations); chronic CMV drives immunosenescence
- HSV-1 establishes latency in trigeminal ganglia; stress-induced reactivation causes cold sores
- Viral damage to mitochondria releases mtDNA → TLR9 activation → sustained inflammation (Long COVID mechanism)
- Acute viral infection increases basal metabolic rate by 13-30%, requiring caloric surplus and micronutrient density
- Mutations can result from viral integration: retroviruses (HIV) permanently insert DNA into host genome; influenza reassortment creates pandemic strains
- NK cells kill infected cells displaying reduced MHC I (viral immune evasion strategy)
- Interferon-gamma (IFN-γ) from Th1 cells activates macrophages (M1 polarization) for enhanced antiviral activity
- innate immunity — viruses are recognized as PAMPs by TLRs, triggering immediate interferon and inflammatory responses
- TLRs — TLR3 (dsRNA), TLR7/8 (ssRNA), TLR9 (CpG DNA) are the primary viral pattern recognition receptors
- interferon — Type I interferon (IFN-α/β) induces antiviral state in neighboring cells, activates NK cells, promotes Th1 differentiation
- Th1 cells — Th1 cellular immunity (IFN-γ production) is essential for clearing intracellular viral infections
- cytotoxic T cells — CD8+ T cells recognize viral peptides on MHC Class I and kill infected cells via perforin/granzyme
- NK cells — natural killer cells provide early antiviral defense by killing cells with downregulated MHC I
- adaptive immunity — viral infections activate T cell-mediated immunity with memory formation for long-term protection
- PAMPs — viral nucleic acids (dsRNA, ssRNA, CpG DNA) are pathogen-associated molecular patterns detected by innate sensors
- inflammation — viral infection triggers systemic inflammatory response requiring massive energy expenditure (fever, APR)
- mitochondria — viral proteases damage mitochondria, releasing mtDNA that perpetuates inflammation post-infection
- Long COVID — persistent mitochondrial dysfunction and mtDAMP release may drive ongoing neuroinflammation and fatigue
- EBV — Epstein-Barr virus establishes latency in B cells, requiring chronic immune surveillance; linked to MS, CFS
- CMV — cytomegalovirus persists latently in myeloid cells, reactivates during stress, drives immunosenescence
- vitamin D — enhances cathelicidin and beta-defensin production; maintains Th1/Th2 balance; clinical target >75 nmol/L
- zinc — essential for thymulin secretion, IFN-γ signaling, and viral polymerase inhibition (15-30 mg/day)
- fever — viral infections trigger hypothalamic set-point elevation to 38.5-40°C, enhancing immune function and inhibiting viral replication
- mutations — retroviruses integrate DNA into host genome; viral mutagenesis drives cancer (HPV, EBV, HBV)
- MHC Class I — all nucleated cells display intracellular peptides on MHC I for CD8+ T cell surveillance
- energy metabolism — antiviral immunity increases BMR by 13-30%, requiring glucose, amino acids, and micronutrient sufficiency
- immune exhaustion — chronic viral infections (HIV, HCV, chronic EBV) cause T cell exhaustion via PD-1/PD-L1 upregulation
- HSV — herpes simplex virus establishes latency in sensory ganglia; stress-induced reactivation via cortisol-mediated immune suppression
- sickness behaviour — IL-1β, TNF-α, IL-6 from viral infection activate vagal afferents → hypothalamic inflammation → anorexia, lethargy, social withdrawal
- chronic stress — elevates cortisol → suppresses Th1 immunity → reactivates latent viruses (EBV, CMV, HSV)
- mtDAMPs — mitochondrial DAMPs (mtDNA, formyl peptides) released during viral infection activate TLR9 and NLRP3 inflammasome
- Type 1 diabetes — enteroviruses (Coxsackie B) may trigger autoimmune destruction of pancreatic beta-cells via molecular mimicry
- COVID-19 — SARS-CoV-2 enters via ACE2 receptor; severe disease involves cytokine storm, endothelial damage, mitochondrial dysfunction
- autophagy — viruses hijack autophagic machinery for replication; conversely, autophagy (via fasting, rapamycin) can clear viral components
- sleep — deep NREM sleep enhances interferon production and T cell priming; sleep deprivation impairs antiviral immunity
- selenium — selenoproteins (glutathione peroxidase) protect against oxidative damage during viral infection; deficiency worsens viral pathogenicity
- molecular mimicry — viral peptides share homology with self-antigens (e.g., EBV EBNA1 mimics myelin basic protein in MS)
- Module 2 — Evolutionary Medicine: viral evolution, founder effects (FOXP2 mutation), molecular mimicry
- Module 4 — Pain: viral infections activate nociceptive pathways via IL-1β, TNF-α, PGE2; post-viral neuropathic pain
- Module 5 — Wound Healing: viruses as pathogenic triggers activating innate immunity and Th1 differentiation